In 2025, Weight Watchers filed for Chapter 11 bankruptcy after reporting revenue and profit losses for multiple consecutive years, with its stock price losing about 99% of its value between 2018 and 2025.

The Heinz Company acquired Weight Watchers for $71M in 1978 before selling the company to private equity firm Artal Luxembourg in 1999 for about $735M—more than 10 times the amount Heinz paid for it.

Weight Watchers began offering access to GLP-1 weight-loss medications in 2023 after losing more than 1.5 million members over the previous two years.

Weight Watchers founder Jean Nidetch had a gambling problem, burning through the $7M she made from the company's sale to Heinz after moving to Las Vegas.

Queens, New York, housewife Jean Nidetch founded Weight Watchers in 1963 after someone mistook her for being pregnant.

Weight Watchers briefly changed its name to 'WW' in 2018 before quietly changing it back to Weight Watchers a few years later.

In 2018, Weight Watchers announced a free program for teens as young as 13—and faced significant backlash from the eating disorder recovery community as a result.

From Ozempic to Wegovy, see the $58B weight loss drug market visualized in one chart.

What do people do once GLP-1 medications succeed at weight loss?

The drugs have been adopted by 1 in 8 Americans, with many achieving their prescribed weight loss. They now face the question of how to keep the weight off, the key issue with any weight loss program that researchers have known about for decades. Each case is unique. Some folks continue to use GLP-1s like Ozempic in minuscule doses, while others taper them off over time.

In 2023, Americans spent more than $50B on weight loss drugs, a number expected to triple or more by the end of the decade.

How self-care led to Ozempic's success

Self-care has become a $1.5T economy that idealizes restraint and willpower, leaving behind those who can't shake off human nature. This article explores how Ozempic and similar weight loss medications pick up where self-care left off.

Celebrities are able to promote prescription drugs on social media without any required mention of potential side effects due to a legal loophole.

'Weight cycling'—when someone repeatedly loses and gains weight—can harm an individual's metabolism.

See the trailer for the 2017 HBO movie 'The Immortal Life of Henrietta Lacks' starring Oprah Winfrey, who plays the daughter of the Black woman whose cancer cells were taken without her knowledge or permission, and now underpin numerous scientific discoveries.

Research suggests Ozempic has benefits beyond weight loss

Semaglutide, the key ingredient in Ozempic, is proving to be more than just a diabetes and weight loss drug. Research suggests it may also help prevent strokes, improve heart health, and slow Alzheimer’s.

Companies developing new weight loss drugs

In recent years, weight loss drugs made a tremendous amount of money for Novo Nordisk and Eli Lilly. Other companies are developing new drugs to break into the market. This piece is a concise overview of companies creating and testing new drugs, how far along they are, and what Novo Nordisk and Eli Lilly are doing to compete with these emerging rivals.

Some Ozempic users lose their desire to eat

This essay follows a writer whose Ozempic journey involves a dramatic loss of appetite, leading them to stop compulsive snacking and even lose some of the joy of eating. As a result, he becomes fixated on watching food videos and eventually tries to "beat" an all-you-can-eat steak buffet. The experience leaves him feeling disappointed and lacking in desire.

History's weirdest weight loss fads, fact-checked

Nothing catches popular attention more than a claim to have found a quick weight-loss technique. History shows us such claims are often unfounded. Dr. Michael Mosley explores extreme weight-loss tips from history, from tapeworms to vinegar diets.

When people stopped using GLP-1, they regained two-thirds of the weight back.

Advertising powerhouse Mary Wells Lawrence became the first female CEO of a public company listed on the NYSE when her ad agency went public in 1968.

Can you microdose GLP-1 agonists like Ozempic?

GLP-1 agonists like Ozempic can help with weight loss, diabetes, and anti-inflammation. For some users, normal doses are too much. So, they've started "microdosing"—taking a smaller amount than the lowest increment of the drug available. While not yet backed by clinical trials, some doctors observed positive effects for certain people.

Advertising holding company WPP acquired Ogilvy & Mather in 1989 for $864M

It was the largest amount ever paid for an agency at the time. WPP, which acquired agency J. Walter Thompson for $566M just two years before the Ogilvy & Mather acquisition, still owns Ogilvy today.

The popularity of new weight loss drugs has led to a diabetes treatment shortage

The FDA approved Ozempic to help patients with diabetes, but the popularity of semaglutide as a weight loss drug led doctors to prescribe Ozempic to nondiabetic patients who needed to lose weight. Ozempic became so popular that manufacturers could not keep pace with demand, posing risks for Ozempic-users with diabetes.

Dove’s ‘Real Beauty’ campaign sparked conversations about beauty standards in media

For the 20-year anniversary of the campaign in 2024, Dove conducted a brand-commissioned study to gauge how perceptions of beauty standards have shifted since its launch. While 81% of US women thought “the media and advertising set an unrealistic standard of beauty that most women can’t ever achieve” in 2004, the share had shrunk to 69% in 2024. Watch the ad here.

12% of adults were taking injectable GLP-1 for weight loss according to 2025 survey

Weight loss injectable use rose sharply between 2024 and fall 2025. The percentage of adults who reported taking this class of medicine specifically for weight loss increased to 12.4%, compared with 5.8% in February 2024 when Gallup first measured it.

How weight loss drugs could reduce obesity costs

A detailed analysis from finance giant ING finds semaglutide and other weight loss drugs could significantly drive down global costs stemming from heart disease and other health problems associated with obesity. The benefits will vary, depending on each country’s demographics and drug and healthcare costs.

Who is wellness scammer Belle Gibson?

A new Netflix drama series called “Apple Cider Vinegar” tells a story inspired by the real-life scandal of Belle Gibson. Gibson falsely claimed to have healed herself of terminal brain cancer through healthy eating. She built a successful wellness empire without any medical background until journalists eventually found inaccuracies in her story. Discover more about the woman who founded a business on deception, how she got caught, and where she is now.

Read about why Bumble founder Whitney Wolfe Herd stepped down as CEO in 2024 only to return in 2025

When Wolfe Herd stepped down as CEO in 2024, assuming an executive chair role, she said she was eager to return to her "founder roots" and do more big-picture thinking. However, when her replacement as CEO, the former Slack CEO Lidiane Jones, left the company "for personal reasons," Wolfe Herd once again assumed the CEO role. (Some users may experience a paywall.)

An interview with Laurene Powell Jobs

Steve Jobs is survived by his wife Laurene Powell Jobs, who has spent her career supporting social causes. Powell Jobs said she’s working to distribute the billions of dollars she received from her late husband.

Insurance coverage for GLP-1s remains uneven, but Medicare began covering it in some instances in July 2026.

Many of the 2010s girlboss-era founders experienced a public fall from grace in 2020

In the 2010s, dozens of female founders were celebrated on the covers of business magazines like Inc. for their recent startup success, from Emily Weiss’s Glossier makeup brand to Steph Korey’s Away luggage company. But many of these companies were also the subject of large takedown articles around the year 2020.

Medicare in early 2026 did not pay for GLP-1 for obesity treatment, and coverage under Medicaid varied widely by state.

The controversial 'Peloton Wife' ad from 2019 cost the company more than $1B in market value

The 2019 ad of a man gifting his wife a Peloton exercise bike sparked a wave of controversy, with some calling the ad sexist and fatphobic. The ad's backlash decreased the company's market value by $1.6B.

Despite many influencers having loyal followings, creator-led brands often fail when the hype from first-time buyers dies down and doesn't translate into repeat purchases.

'Telephone, telegraph, tell a woman:' Listen to Estée Lauder's legendary vision for word-of-mouth marketing

Without a large advertising budget, Lauder focused her marketing strategy on making high-quality products that women would love enough to tell their friends about. Those friends would later inevitably buy Estée Lauder products.

Watch the infamous live feud between Bill Ackman and Carl Icahn from 2013 in the fallout of a billion-dollar accusation that Herbalife was a pyramid scheme.

Whitney Wolfe Herd's return as CEO boosted Bumble's declining stock price

While the uptick didn't last, when Bumble announced Founder Wolfe Herd's return in 2025, shares rose in premarket trading and later that day. Investors likely hoped that her strategy could restabilize the business.